Cargando…

Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy

IL-17 and related cytokines are direct and indirect targets of selective immunosuppressive agents for the treatment of autoimmune diseases and other diseases of pathologic inflammation. Insights into the potential adverse effects of IL-17 blockade can be drawn from the experience of patients with de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huppler, Anna R, Bishu, Shrinivas, Gaffen, Sarah L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580547/ https://www.ncbi.nlm.nih.gov/pubmed/22838497 http://dx.doi.org/10.1186/ar3893

Ejemplares similares

Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis
por: Huppler, Anna R., et al.
Publicado: (2015)

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity
por: Okada, Satoshi, et al.
Publicado: (2016)

Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis
por: Ling, Yun, et al.
Publicado: (2015)

IL‐17 serum level in patients with chronic mucocutaneous candidiasis disease
por: Chimenz, Roberto, et al.
Publicado: (2022)

Isolated chronic mucocutaneous candidiasis due to a novel duplication variant of IL17RC
por: Noma, Kosuke, et al.
Publicado: (2023)

C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins
por: Simpson-Abelson, Michelle R., et al.
Publicado: (2015)

Signaling through IL-17C/IL-17RE Is Dispensable for Immunity to Systemic, Oral and Cutaneous Candidiasis
por: Conti, Heather R., et al.
Publicado: (2015)

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
por: Puel, Anne, et al.
Publicado: (2010)

Chronic mucocutaneous candidiasis with endocrinopathy – case report
por: Lesiak, Aleksandra, et al.
Publicado: (2010)

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
por: Liu, Luyan, et al.
Publicado: (2011)

Bioadhesive Films Containing Fluconazole for Mucocutaneous Candidiasis
por: Patel, S. K., et al.
Publicado: (2015)

Chronic Mucocutaneous Candidiasis: A Case Report
por: Wang, Zhensheng, et al.
Publicado: (2023)

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
por: Kisand, Kai, et al.
Publicado: (2010)

Immunologic characterization of patients with chronic mucocutaneous candidiasis disease
por: Khalsa, Kiranjit K., et al.
Publicado: (2018)

Mucocutaneous and cutaneous generalized candidiasis in a thymectomized dog
por: Muñoz Declara, Sara, et al.
Publicado: (2022)

Mucocutaneous findings associated with interleukin (IL)-17 inhibition
por: Purnell, J. Chase, et al.
Publicado: (2016)

Chronic mucocutaneous candidiasis presenting as refractory fissured tongue in a patient with IL-17RC mutation: the first reported case of Chinese ethnicity
por: Xie, Yufei, et al.
Publicado: (2023)

A Novel Interleukin 17 Receptor A Mutation in a Child with Chronic Mucocutaneous Candidiasis and Staphylococcal Skin Infections
por: Yakıcı, Nalan, et al.
Publicado: (2023)

Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis
por: Bloomfield, Marketa, et al.
Publicado: (2022)

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
por: Conti, Heather R., et al.
Publicado: (2009)

Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1
por: Humbert, Linda, et al.
Publicado: (2018)

Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies
por: Shamriz, Oded, et al.
Publicado: (2020)

The metabolism-modulating activity of IL-17 signaling in health and disease
por: Bechara, Rami, et al.
Publicado: (2021)

Chronic mucocutaneous candidiasis: a case with exuberant cutaneous horns in nipples()
por: Chambô, Antônio, et al.
Publicado: (2014)

Clinical and immunological data of nine patients with chronic mucocutaneous candidiasis disease
por: Dotta, Laura, et al.
Publicado: (2016)

Case for diagnosis. Disseminated erythematous and scaly plaques: chronic mucocutaneous candidiasis()
por: Abreu, Nathalia Chebli de, et al.
Publicado: (2023)

Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis
por: Pietrella, Donatella, et al.
Publicado: (2011)

149. Efficacy of Cochleated Amphotericin B (CAMB) in Mouse and Human Mucocutaneous Candidiasis
por: Desai, Jigar V, et al.
Publicado: (2020)

IL-17 signaling and A20: A balancing act
por: Garg, Abhishek V, et al.
Publicado: (2013)

STAT1 Hyperphosphorylation and Defective IL12R/IL23R Signaling Underlie Defective Immunity in Autosomal Dominant Chronic Mucocutaneous Candidiasis
por: Smeekens, Sanne P., et al.
Publicado: (2011)

Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses
por: Bishu, Shrinivas, et al.
Publicado: (2014)

101 Case Report: Recurrent Mucocutaneous Candidiasis and Recurrent Diarrhea by Gram Negative Bacteria
por: Becerra, Juan Aldave
Publicado: (2012)

Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole
por: Firinu, Davide, et al.
Publicado: (2011)

Clonal Strain Persistence of Candida albicans Isolates from Chronic Mucocutaneous Candidiasis Patients
por: Moorhouse, Alexander J., et al.
Publicado: (2016)

Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis
por: Zhang, Ming-rui, et al.
Publicado: (2020)

Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors
por: Borgström, Emilie W., et al.
Publicado: (2022)

Autoimmunity and cystatin SA 1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome
por: Lindh, Emma, et al.
Publicado: (2012)

Th17 cells confer long term adaptive immunity to oral mucosal Candida albicans infections
por: Hernández-Santos, Nydiaris, et al.
Publicado: (2012)

Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections
por: Conti, Heather R., et al.
Publicado: (2014)

Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure
por: Veerdonk, FL van de, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_j39h3dlaooslotghi14kb3da9c